
Treatment GuideJust DiagnosedSex & DatingAfrican AmericanStigmaAsk the HIV DocPrEP En EspañolNewsVoicesPrint IssueVideo
CONTACTCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2023 Pride Publishing Inc.
All Rights reserved
All Rights reserved
Scroll To Top
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The Food and Drug Administration recently approved Gamunex, an immune globulin intravenous therapy, for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a condition characterized by progressive weakness and impaired sensory function in the arms and legs. Immune globulin products are obtained from pooled human blood plasma, which contains infection-fighting antibodies, and are often given to HIVers at risk for certain infectious diseases. It is estimated that CIDP affects about 25,000 Americans.
From our Sponsors
Most Popular
Plus: Featured Video